162 related articles for article (PubMed ID: 21369848)
21. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.
Voltz R; Gultekin SH; Rosenfeld MR; Gerstner E; Eichen J; Posner JB; Dalmau J
N Engl J Med; 1999 Jun; 340(23):1788-95. PubMed ID: 10362822
[TBL] [Abstract][Full Text] [Related]
22. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
Turkçapar N; Olmez U; Tutkak H; Duman M
Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
[TBL] [Abstract][Full Text] [Related]
23. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
[TBL] [Abstract][Full Text] [Related]
24. Late development of anti-La/SS-B antibodies in a patient with Sjogren's syndrome and high titer anti-Ro/SS-A antibodies.
Satoh M; Hamilton KJ; Langdon JJ; Akizuki M; Yamagata H; Nakayama S; Reeves WH; Homma M
Lupus; 1996 Aug; 5(4):337-9. PubMed ID: 8869909
[TBL] [Abstract][Full Text] [Related]
25. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
26. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.
Benyahia B; Amoura Z; Rousseau A; Le Clanche C; Carpentier A; Piette JC; Delattre JY
J Neurooncol; 2003 May; 62(3):349-51. PubMed ID: 12777089
[TBL] [Abstract][Full Text] [Related]
27. Seronegative limbic encephalitis in association with Sjögren's syndrome: a rare case report.
George S; Baby N; Gilvaz P; Thangheswaran H; Poovathingal MA; Baby A
Pan Afr Med J; 2022; 41():52. PubMed ID: 35317474
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
[TBL] [Abstract][Full Text] [Related]
31. Sjögren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu.
Carvalho DC; Tironi TS; Freitas DS; Kleinpaul R; Talim NC; Lana-Peixoto MA
Arq Neuropsiquiatr; 2014 Aug; 72(8):619-24. PubMed ID: 25098478
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to Ro and La.
Reichlin M
Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
[TBL] [Abstract][Full Text] [Related]
33. Sjögren's syndrome with rapidly progressive motor neuron disease: a case report.
Yang H; Jing X; Yan J; Ma D
J Int Med Res; 2020 Nov; 48(11):300060520974465. PubMed ID: 33233989
[TBL] [Abstract][Full Text] [Related]
34. Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis.
Pericot I; Brieva L; Tintoré M; Río J; Sastre-Garriga J; Nos C; Montalban X
Mult Scler; 2003 Jun; 9(3):256-9. PubMed ID: 12814172
[TBL] [Abstract][Full Text] [Related]
35. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?
Scofield AN; Kurien BT; Gordon TP; Scofield RH
Lupus; 2001; 10(8):547-53. PubMed ID: 11530996
[TBL] [Abstract][Full Text] [Related]
36. Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.
Ramos-Casals M; Brito-Zerón P; Perez-De-Lis M; Jimenez I; Blanco MJ; Bove A; Soto MJ; Akasbi M; Diaz C; Sentís J; Siso A
Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):178-85. PubMed ID: 19578996
[TBL] [Abstract][Full Text] [Related]
37. Bilateral facial paralysis as a rare neurological manifestation of primary Sjögren's syndrome: case-based review.
Wei Z; Jiaying S; Junhong G
Rheumatol Int; 2019 Sep; 39(9):1651-1654. PubMed ID: 31175417
[TBL] [Abstract][Full Text] [Related]
38. Sjögren Syndrome and Other Causes of Sicca in Older Adults.
Baer AN; Walitt B
Clin Geriatr Med; 2017 Feb; 33(1):87-103. PubMed ID: 27886700
[TBL] [Abstract][Full Text] [Related]
39. Sjogren's syndrome.
Soliotis FC; Moutsopoulos HM
Autoimmunity; 2004 Jun; 37(4):305-7. PubMed ID: 15518047
[No Abstract] [Full Text] [Related]
40. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
Whittingham S; Mackay IR; Tait BD
Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
